We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
139 hedge funds and large institutions have $1.5B invested in Atara Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 51 increasing their positions, 47 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
287% more call options, than puts
Call options by funds: $1.01M | Put options by funds: $261K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
9% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 47
0.07% more ownership
Funds ownership: 4.23% → 4.31% (+0.07%)
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
1% less funds holding
Funds holding: 140 → 139 (-1)
7% less capital invested
Capital invested by funds: $1.61B → $1.5B (-$106M)
Holders
139
Holders Change
-1
Holders Change %
-0.71%
% of All Funds
2.14%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
15
Increased
51
Reduced
47
Closed
15
Calls
$1.01M
Puts
$261K
Net Calls
+$748K
Net Calls Change
+$472K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$38.7M |
| 2 |
EC
Eminence Capital
New York
|
+$19.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$19M |
| 4 |
Citigroup
New York
|
+$12.5M |
| 5 |
N
Natixis
Paris,
France
|
+$10.7M |
Top Sellers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$14.9M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$13.5M |
| 3 |
JP Morgan Chase
New York
|
-$10.1M |
| 4 |
LPC
Lion Point Capital
New York
|
-$6.27M |
| 5 |
Two Sigma Advisers
New York
|
-$5.51M |
